Anda belum login :: 17 Feb 2025 08:51 WIB
Detail
ArtikelFactors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes  
Oleh: Beck, Roy W.
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Diabetes Care vol. 32 no. 11 (Nov. 2009), page 1947-1953.
Topik: DIABETES MELLITUS; DIABETES; continuous glucose monitoring; type 1 diabetes
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: D05.K.2009.03
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelOBJECTIVE : To evaluate factors associated with successful use of continuous glucose monitoring (CGM) among participants with intensively treated type 1 diabetes in the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Clinical Trial. RESEARCH DESIGN AND METHODS : The 232 participants randomly assigned to the CGM group (165 with baseline A1C =7.0% and 67 with A1C <7.0%) were asked to use CGM on a daily basis. The associations of baseline factors and early CGM use with CGM use =6 days/week in the 6th month and with change in A1C from baseline to 6 months were evaluated in regression models. RESULTS : The only baseline factors found to be associated with greater CGM use in month 6 were age =25 years (P < 0.001) and more frequent self-reported prestudy blood glucose meter measurements per day (P < 0.001). CGM use and the percentage of CGM glucose values between 71 and 180 mg/dl during the 1st month were predictive of CGM use in month 6 (P < 0.001 and P = 0.002, respectively). More frequent CGM use was associated with a greater reduction in A1C from baseline to 6 months (P < 0.001), a finding present in all age-groups. CONCLUSIONS : After 6 months, near-daily CGM use is more frequent in intensively treated adults with type 1 diabetes than in children and adolescents, although in all age-groups near-daily CGM use is associated with a similar reduction in A1C. Frequency of blood glucose meter monitoring and initial CGM use may help predict the likelihood of long-term CGM benefit in intensively treated patients with type 1 diabetes of all ages.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)